Its subsidiary, Humber Industrials Ltd., has reached an agreement to purchase Novartis UK's 170-acre API manufacturing plant site and assets in Grimsby, UK.
100 subject matter experts were surveyed from smaller biotech innovators to gain insight into the dynamics and drivers of the current biologics market.
A case study on how Recipharm developed a suitable analysis method for Lobsor Pharmaceutical's advanced Parkinson’s disease treatment, Lecigon® intestinal gel.
Read this case study to see how Societal CDMO leveraged innovative processing equipment from Freund-Vector to develop an efficient — and effective — solution.
Technological advancements, global market dynamics, and patient-centric approaches are all factors driving the transformation of the parenteral drug market.
Jeff Clement, Executive Director, Technical Sales – Development and Manufacturing, PCI Pharma Service
The temperature of chromatographic operations at manufacturing scale which utilize a chilled mobile phase can be difficult to replicate in a scale down model.
Learn about USP products and solutions including USP reference samples, Compounding Compendium, Dietary Supplement Verification, education courses and more.
The biologics CDMO selected for a given product or program is critical to an innovator’s ability to deliver a drug product safely, on time, and on budget.